Arkolith/Insider Trading/TRAW/Form 4

Savchuk Nikolay

Chief Operating Officer, 10% OwnerTraws Pharma, Inc. (TRAW) · full profile →Form 4 · filed Apr 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2025Other(J)606K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 2, 2025Other(J)2K—$00

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-033149) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML